BayWa's Restructuring Plan Faces Mounting Pressure

BayWa's debt reduction strategy is faltering as market turmoil threatens the sale of its renewable energy unit, creating a 2.7B euro funding gap despite recent asset sales.

The German conglomerate BayWa is encountering significant turbulence in its multi-year debt reduction strategy. While recent asset sales have provided some balance sheet relief, a critical pillar of the plan—the partial divestment of its renewable energy subsidiary—is now showing cracks, casting doubt on the feasibility of meeting its 2028 targets.

Core Debt Reduction Strategy Under Threat

Central to BayWa's restructuring is a goal to reduce debt by a total of 4 billion euros by 2028. The company had earmarked approximately 2 billion euros of this sum to come from the sale of majority stakes in its subsidiary, BayWa r.e. This cornerstone is now under pressure. On February 2, the company issued an ad-hoc announcement revealing "significant deviations" in BayWa r.e.'s business planning. Management cited substantial market changes for renewable energy in both the USA and Europe, which are expected to lower the total proceeds from the planned stake sale through the end of 2028.

The US market is a particularly sensitive point, having been BayWa r.e.'s most important in 2024 with 534.7 megawatts of capacity sold. Regulatory headwinds in this key region are therefore hitting at a vulnerable spot. These uncertainties are also impacting financial reporting, causing a delay in the audited financial statements for 2025. BayWa has proactively initiated discussions with its financiers to potentially adjust the restructuring concept.

Recent Sales Offer Partial Relief

In a positive development, BayWa has completed the previously announced sale of its Dutch subsidiary, Cefetra. The transaction, finalized after an initial attempt failed in autumn 2025 due to buyer financing issues, fetched a purchase price of 125 million euros. The more substantial impact, however, comes from deconsolidation: this move reduces BayWa's bank liabilities by over 600 million euros as Cefetra's debt is removed from the group's accounts.

Combined with other divestments executed in 2025—including RWA, WHG, and EDL—the company has lowered its bank debt by approximately 1.3 billion euros since that year. Despite this progress, a funding gap of about 2.7 billion euros remains to be achieved by the 2028 deadline.

Operational Downsizing and Leadership Turmoil

Alongside asset sales, BayWa is pursuing a broad operational contraction. The company plans to reduce its revenue to around 10 billion euros by 2028. This will involve cutting roughly 1,300 jobs by 2027, with the central administration slated to lose about 40% of its positions. Furthermore, 26 of its more than 400 global branches are scheduled for closure.

The next planned divestment is the New Zealand-based subsidiary Turners & Growers (T&G Global) in 2026, which industry insiders suggest could contribute around 300 million euros to debt reduction.

Significant upheaval continues at the executive level. CEO Dr. Frank Hiller will depart "by mutual agreement" on July 31, 2026, with his mandate ending immediately. Supervisory board members Monika Hohlmeier and Michael Höllerer will step down at the end of March, followed by Monique Surges at the end of May. Internally, control mechanisms have been tightened, requiring approval for transactions exceeding 50 million euros, down from the previous threshold of 200 million euros.

Regulatory Scrutiny and a Crucial Date

Adding to the company's challenges, Germany's financial regulator, BaFin, has been conducting a review of the 2023 annual financial statements since October 2024. BayWa had also previously received a regulatory fine for delayed data submission.

All eyes are now on March 26, when BayWa will release its Q4 2025 figures. This date is seen as a key indicator for assessing the viability of the core objective to shed 4 billion euros in debt by 2028, especially in light of the emerging complications at BayWa r.e.